{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:15:26Z","timestamp":1788884126682,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Paraganglioma occurs rarely in the sellar\/parasellar region. Here, we report a patient with malignant paraganglioma with primary sellar location with unusual genetic and imaging features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>A 31-year-old male presented with mild hypertension, headache, nausea, and vomiting. A sellar\/parasellar tumor mass was revealed by magnetic resonance imaging (MRI), while an endocrine work-up found partial hypopituitarism, suggesting that it was a non-functioning pituitary tumor. Antihypertensive therapy and hormone replacement were initiated. Tumor reduction was achieved with transsphenoidal neurosurgery. However, histological diagnosis was not possible due to extensive tissue necrosis. After 4 years of stable disease, the residual tumor showed re-growth requiring gamma knife radiosurgery. Four years after the radiosurgery, MRI showed a significant tumor progression leading to a second neurosurgery. This time, pathological and immunohistochemical findings revealed paraganglioma. Plasma levels of metanephrine and normetanephrine were normal. A gene sequencing panel performed on DNA extracted from blood excluded germline mutations in 17 susceptibility genes. The patient developed new tumor masses in the neck, and the third surgery was performed. Immunohistochemistry demonstrated lack of ATRX (alpha thalassemia\/mental retardation syndrome X-linked) protein in tumor cells, indicating an <jats:italic>ATRX<\/jats:italic> gene mutation. Molecular genetic analysis performed on tumor DNA revealed a combination of <jats:italic>ATRX<\/jats:italic> and <jats:italic>TP53<\/jats:italic> gene abnormalities; this was not previously reported in paraganglioma. MRI and 68Ga-DOTANOC PET\/CT revealed the full extent of the disease. Therapy with somatostatin LAR and 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) was initiated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although rare, paraganglioma should be considered in the differential diagnosis of sellar\/parasellar tumor lesions, even in the absence of typical imaging features. <jats:italic>ATRX<\/jats:italic> gene mutation in paraganglioma is an early predictor of malignant behavior and a potential novel therapeutic marker when pharmacological therapy targeting mutated ATRX becomes available.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.739255","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T14:08:21Z","timestamp":1638281301000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features"],"prefix":"10.3389","volume":"11","author":[{"given":"Stefan","family":"Stojanoski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning B\u00fcnsow","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusko","family":"Kozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Pat\u00f3cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Medic-Stojanoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Casar-Borota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101505","article-title":"Current Management of Pheochromocytoma\/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine","volume":"11","author":"N\u00f6lting","year":"2019","journal-title":"Cancers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"key":"B3","article-title":"Dopamine Excess in Patients With Head and Neck Paragangliomas","volume":"30","author":"Van Der Horst-Schrivers","year":"2010","journal-title":"Anticancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.01.094","article-title":"Primary Sellar Paraganglioma: Case Report With Literature Review and Immunohistochemistry Resource","volume":"125","author":"Lyne","year":"2019","journal-title":"World Neurosurg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.wneu.2019.02.111","article-title":"Nonsecretory Paraganglioma in Cavernous Sinus Masquerading as Meningioma","volume":"126","author":"Singh","year":"2019","journal-title":"World Neurosurg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-005-1422-4","article-title":"Suprasellar Paraganglioma: A Case Report and Review of the Literature","volume":"47","author":"Naggara","year":"2005","journal-title":"Neuroradiology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2580160","article-title":"Recurrent Primary Intrasellar Paraganglioma","volume":"2020","author":"Schueth","year":"2020","journal-title":"Case Rep Otolaryngol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.wneu.2020.04.157","article-title":"Sellar-Suprasellar Paraganglioma: Report of 2 Cases and Review of Literature","volume":"140","author":"Vasoya","year":"2020","journal-title":"World Neurosurg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000507084","article-title":"Histopathology of Parasellar Neoplasms","volume":"110","author":"Manojlovic-Gacic","year":"2020","journal-title":"Neuroendocrinology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nic.2015.12.005","article-title":"Paragangliomas of the Head and Neck","volume":"26","author":"Woolen","year":"2016","journal-title":"Neuroimaging Clin N Am"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2007.03.029","article-title":"Malignant Paraganglioma of the Sellar Region Mimicking a Pituitary Macroadenoma","volume":"15","author":"Sinha","year":"2008","journal-title":"J Clin Neurosci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175689","article-title":"SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and Paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2016_76","article-title":"Phaeochromocytoma and Paraganglioma","volume":"956","author":"Gunawardane","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0099-1","article-title":"A Rare Case of Paraganglioma of the Sella With Bone Metastases","volume":"12","author":"Haresh","year":"2009","journal-title":"Pituitary"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole- Exome Sequencing Identifies Somatic ATRX Mutations in Pheochromocytomas and Paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0139","article-title":"Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma","volume":"25","author":"Job","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B19","first-page":"125","article-title":"Superiority of 68Ga-DOTATATE PET\/CT Compared to 18F-FDG PET\/CT and MRI of the Spine in the Detection of Spinal Bone Metastases in Metastatic Pheochromocytoma and\/or Paraganglioma. A Meeting Report","volume":"61","author":"Jha","year":"2020","journal-title":"J Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0446","article-title":"Germline and Mosaic Mutations Causing Pituitary Tumours: Genetic and Molecular Aspects","volume":"240","author":"Pepe","year":"2019","journal-title":"J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa749","article-title":"Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations","volume":"106","author":"Casar-Borota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3892\/etm.2021.9859","article-title":"Mutational Landscape and Potential Therapeutic Targets for Sporadic Pancreatic Neuroendocrine Tumors Based on Target Next- Generation Sequencing","volume":"21","author":"Zheng","year":"2021","journal-title":"Exp Ther Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2016.04.058","article-title":"ATRX Driver Mutation in a Composite Malignant Pheochromocytoma","volume":"209","author":"Comino-M\u00e9ndez","year":"2016","journal-title":"Cancer Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1617-1","article-title":"Molecular Evaluation of a Sporadic Paraganglioma With Concurrent IDH1 and ATRX Mutations","volume":"61","author":"Zhang","year":"2018","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/138573","article-title":"Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis","volume":"2015","author":"Luchetti","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz269","article-title":"Simultaneous Occurrence of Germline Mutations of SDHB and TP53 in a Patient With Metastatic Pheochromocytoma","volume":"105","author":"Gniado","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.10.25","article-title":"Pheochromocytoma\/paraganglioma: Recent Updates in Genetics, Biochemistry, Immunohistochemistry, Metabolomics, Imaging and Therapeutic Options","volume":"9","author":"Antonio","year":"2020","journal-title":"Gland Surg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, Diagnosis, Management and Future Directions of Research of Phaeochromocytoma and Paraganglioma: A Position Statement and Consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13139-019-00629-3","article-title":"Role of 68Ga-DOTATATE PET\/CT in a Case of SDHB-Related Pterygopalatine Fossa Paraganglioma Successfully Controlled With Octreotide","volume":"54","author":"Jha","year":"2020","journal-title":"Nucl Med Mol Imaging"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3438","article-title":"TERT Rearrangements Are Frequent in Neuroblastoma and Identify Aggressive Tumors","volume":"47","author":"Valentijn","year":"2015","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0165","article-title":"Molecular Imaging and Radionuclide Therapy of Pheochromocytoma and Paraganglioma in the Era of Genomic Characterization of Disease Subgroups","volume":"26","author":"Ta\u00efeb","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259689","article-title":"Imaging of Pheochromocytoma and Paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for Radionuclide Imaging of Phaeochromocytoma and Paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.739255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T14:08:24Z","timestamp":1638281304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.739255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":33,"alternative-id":["10.3389\/fonc.2021.739255"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.739255","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"article-number":"739255"}}